313 related articles for article (PubMed ID: 17183142)
1. Optimum parameters in a model for tumour control probability, including interpatient heterogeneity: evaluation of the log-normal distribution.
Keall PJ; Webb S
Phys Med Biol; 2007 Jan; 52(1):291-302. PubMed ID: 17183142
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy.
Tsougos I; Mavroidis P; Rajala J; Theodorou K; Järvenpää R; Pitkänen MA; Holli K; Ojala AT; Lind BK; Hyödynmaa S; Kappas C
Phys Med Biol; 2005 Aug; 50(15):3535-54. PubMed ID: 16030381
[TBL] [Abstract][Full Text] [Related]
3. Limitations of a TCP model incorporating population heterogeneity.
Warkentin B; Stavrev P; Stavreva NA; Fallone BG
Phys Med Biol; 2005 Aug; 50(15):3571-88. PubMed ID: 16030383
[TBL] [Abstract][Full Text] [Related]
4. A general tumour control probability model for non-uniform dose distributions.
González SJ; Carando DG
Math Med Biol; 2008 Jun; 25(2):171-84. PubMed ID: 18515259
[TBL] [Abstract][Full Text] [Related]
5. Comparison of predicted and clinical response to radiotherapy: a radiobiology modelling study.
Hedman M; Bjork-Eriksson T; Mercke C; West C; Hesselius P; Brodin O
Acta Oncol; 2009; 48(4):584-90. PubMed ID: 19107620
[TBL] [Abstract][Full Text] [Related]
6. The impact of different dose-response parameters on biologically optimized IMRT in breast cancer.
Ferreira BC; Mavroidis P; Adamus-Górka M; Svensson R; Lind BK
Phys Med Biol; 2008 May; 53(10):2733-52. PubMed ID: 18448874
[TBL] [Abstract][Full Text] [Related]
7. EUCLID: an outcome analysis tool for high-dimensional clinical studies.
Gayou O; Parda DS; Miften M
Phys Med Biol; 2007 Mar; 52(6):1705-19. PubMed ID: 17327657
[TBL] [Abstract][Full Text] [Related]
8. The use of spatial dose gradients and probability density function to evaluate the effect of internal organ motion for prostate IMRT treatment planning.
Jiang R; Barnett RB; Chow JC; Chen JZ
Phys Med Biol; 2007 Mar; 52(5):1469-84. PubMed ID: 17301465
[TBL] [Abstract][Full Text] [Related]
9. Analytic investigation into effect of population heterogeneity on parameter ratio estimates.
Schinkel C; Carlone M; Warkentin B; Fallone BG
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1323-30. PubMed ID: 17884301
[TBL] [Abstract][Full Text] [Related]
10. Predicting the radiation control probability of heterogeneous tumour ensembles: data analysis and parameter estimation using a closed-form expression.
Fenwick JD
Phys Med Biol; 1998 Aug; 43(8):2159-78. PubMed ID: 9725596
[TBL] [Abstract][Full Text] [Related]
11. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models.
Rancati T; Wennberg B; Lind P; Svane G; Gagliardi G
Radiother Oncol; 2007 Mar; 82(3):308-16. PubMed ID: 17224197
[TBL] [Abstract][Full Text] [Related]
12. Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships.
El Naqa I; Suneja G; Lindsay PE; Hope AJ; Alaly JR; Vicic M; Bradley JD; Apte A; Deasy JO
Phys Med Biol; 2006 Nov; 51(22):5719-35. PubMed ID: 17068361
[TBL] [Abstract][Full Text] [Related]
13. Single-cell-based computer simulation of the oxygen-dependent tumour response to irradiation.
Harting C; Peschke P; Borkenstein K; Karger CP
Phys Med Biol; 2007 Aug; 52(16):4775-89. PubMed ID: 17671335
[TBL] [Abstract][Full Text] [Related]
14. TCP and NTCP in preclinical and clinical research in Europe.
Baumann M; Petersen C; Krause M
Rays; 2005; 30(2):121-6. PubMed ID: 16294904
[TBL] [Abstract][Full Text] [Related]
15. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.
Yaromina A; Krause M; Thames H; Rosner A; Krause M; Hessel F; Grenman R; Zips D; Baumann M
Radiother Oncol; 2007 Jun; 83(3):304-10. PubMed ID: 17517444
[TBL] [Abstract][Full Text] [Related]
16. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.
Mackay RI; Hendry JH
Radiother Oncol; 1999 Jan; 50(1):67-75. PubMed ID: 10225559
[TBL] [Abstract][Full Text] [Related]
17. Comparison between the ideal reference dose level and the actual reference dose level from clinical 3D radiotherapy treatment plans.
Bufacchi A; Arcangeli G; delle Canne S; Malatesta T; Capparella R; Fragomeni R; Marmiroli L; Begnozzi L
Radiother Oncol; 2009 Jul; 92(1):68-75. PubMed ID: 19328571
[TBL] [Abstract][Full Text] [Related]
18. Biologically effective dose-response relationship for breast cancer treated by conservative surgery and postoperative radiotherapy.
Plataniotis GA; Dale RG
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):512-7. PubMed ID: 19625139
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric parameters in partial breast irradiation through brachytherapy.
Gloi A; McCourt S; Buchanan R; Goetller A; Zuge C; Balzoa P; Cooley G
Med Dosim; 2009; 34(3):207-13. PubMed ID: 19647630
[TBL] [Abstract][Full Text] [Related]
20. A four-dimensional simulation model of tumour response to radiotherapy in vivo: parametric validation considering radiosensitivity, genetic profile and fractionation.
Dionysiou DD; Stamatakos GS; Uzunoglu NK; Nikita KS; Marioli A
J Theor Biol; 2004 Sep; 230(1):1-20. PubMed ID: 15275995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
